U.S. markets closed
  • S&P 500

    3,271.03
    -119.65 (-3.53%)
     
  • Dow 30

    26,519.95
    -943.24 (-3.43%)
     
  • Nasdaq

    11,004.87
    -426.48 (-3.73%)
     
  • Russell 2000

    1,543.28
    -47.21 (-2.97%)
     
  • Crude Oil

    37.33
    -2.24 (-5.66%)
     
  • Gold

    1,876.60
    -35.30 (-1.85%)
     
  • Silver

    23.43
    -1.14 (-4.62%)
     
  • EUR/USD

    1.1754
    -0.0036 (-0.31%)
     
  • 10-Yr Bond

    0.7810
    +0.0030 (+0.39%)
     
  • GBP/USD

    1.2985
    -0.0056 (-0.43%)
     
  • USD/JPY

    104.3100
    -0.1840 (-0.18%)
     
  • BTC-USD

    13,206.04
    +4.55 (+0.03%)
     
  • CMC Crypto 200

    260.91
    -11.78 (-4.32%)
     
  • FTSE 100

    5,582.80
    -146.19 (-2.55%)
     
  • Nikkei 225

    23,418.51
    -67.29 (-0.29%)
     

Mercury Systems (MRCY) Looks Good: Stock Adds 6.2% in Session

Zacks Equity Research
·2 mins read

Mercury Systems, Inc. MRCY was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is now down 11.6% in the past one-month time frame.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Mercury Systems currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Mercury Systems Inc Price

Mercury Systems Inc Price
Mercury Systems Inc Price

Mercury Systems Inc price | Mercury Systems Inc Quote

Another stock worth considering in the Computer - Peripheral Equipment industry is LG Display Co., Ltd. LPL which carries a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
LG Display Co., Ltd. (LPL) : Free Stock Analysis Report
 
Mercury Systems Inc (MRCY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research